New Jersey A943 mandates health insurance coverage for prescribed anti-obesity medication.
New Jersey A943 requires health insurance coverage for prescribed anti-obesity medication. This includes hospital or medical expense benefits provided by various entities such as insurance companies, hospital service corporations, and health maintenance organizations. The coverage must be offered to the same extent as for any other medical condition. The bill defines "anti-obesity medication" as any medication approved by the U.S. Food and Drug Administration for chronic weight management in patients with obesity.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.